NICE (NICE) is lower by roughly 4% in U.S. trading as Wall Street continues to reprice the stock following new research notes that reduced price targets. The core pushback is the same theme: NICE is leaning harder into AI, and that strategy implies near-term margin compression while the company spends to support what it frames as medium-term growth acceleration. (tipranks.com)

A notable driver has been a Barclays note cutting its NICE price target to $165 from $200 while keeping an Overweight rating, explicitly pointing to short-term margin pressure from increased AI investment and a lower valuation multiple. The market reaction has reinforced the idea that, even if AI product momentum improves longer-term positioning, investors are demanding clearer proof points on timing and payback. (tipranks.com)

Adding to the volatility, deal chatter around NICE’s intent to acquire Cognigy has circulated this week, pitching the move as a way to integrate agentic and conversational AI into the CXone platform across voice and digital channels in 100+ languages. While strategically aligned with NICE’s AI-first narrative, M&A introduces integration risk and can amplify near-term concerns about expenses and execution. (martech360.com)

The next checkpoints are whether NICE reiterates or updates its 2026 outlook—currently calling for non-GAAP revenue of $3.17B–$3.19B and non-GAAP EPS of $10.85–$11.05—and whether commentary suggests AI spend is front-loaded or longer lasting. Traders will also focus on whether capital return (including the board-authorized repurchase capacity) becomes more active if the stock continues sliding. (resources.nice.com)